First in Human Study to Test the Safety and Preliminary Efficacy of PPSGG in Patients With Anti-MAG Neuropathy
NCT04568174
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class
Stopped
Data don't support further development
Conditions
Anti-MAG Neuropathy
Interventions
DRUG:
PPSGG
DRUG:
Placebo
Sponsor
Polyneuron Pharmaceuticals AG